Pacira | PCRX - Capital Social Ordinario

Precio De Mercado
23.79
Cambio Diario
-0.03 -0.13%
Mensual
4.21%
Anual
-3.14%
Q2 Expectativa
22.02




Capital Social Ordinario Cambio Fecha
Assertio Holdings USD 9K 0 2023-12
Astellas Pharma JPY 1.79B 195K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cara Therapeutics USD 9.38M 9.38M 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Heron Therapeutics USD 188.31M 4.99M 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 584K 2025-09
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novo Nordisk DKK 4.44B 0 2025-12
Omeros USD 611K 17K 2023-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Xoma USD 87K 1000 2024-06
Zoetis USD 424.93M 16.54M 2025-12